Trademark applications and grants for Taisho Pharmaceutical Co L T D. Taisho Pharmaceutical Co L T D has 72 trademark applications. The latest application filed is for "LEXTY"
Patent Application | Date |
---|---|
NOVEL IMIDAZOLE DERIVATIVE 20220002279 - 17/295247 TAKASHIMA; Hajime ;   et al. | 2022-01-06 |
METHOD FOR PRODUCING (2S)-2-[(1H-PYRAZOL-1-YL)METHYL]-1,3-OXAZINANE DERIVATIVE 20210147400 - 16/630120 MATSUBARA; Takaaki ;   et al. | 2021-05-20 |
PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE 20210122741 - 16/637595 TANAKA; Hiroaki ;   et al. | 2021-04-29 |
2(1H)-QUINOLINONE DERIVATIVE 20210070747 - 16/496066 AMADA; Hideaki ;   et al. | 2021-03-11 |
METHOD AND COMPOSITION FOR REVERSING COGNITIVE IMPAIRMENTS AND LOSS USING SGLT2 INHIBITORS 20210059984 - 16/556948 FAN; Fan ;   et al. | 2021-03-04 |
SEC | 0001158268 | TAISHO PHARMACEUTICAL CO., LTD. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.